Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Plasma-Cell Myeloma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT02943473
What this trial is testing

Study on the Effect of Ibrutinib on High Risk Smoldering Multiple Myeloma Patients

Who this might be right for
High Risk Smoldering Multiple Myeloma
Icahn School of Medicine at Mount Sinai 9
Testing effectiveness (Phase 2)Study completedNCT00307086
What this trial is testing

Bortezomib Followed by High-Dose Melphalan and Bortezomib as Conditioning Regimen for Tandem Stem Cell Transplants

Who this might be right for
Multiple MyelomaPlasma Cell Leukemia
H. Lee Moffitt Cancer Center and Research Institute 30
Testing effectiveness (Phase 2)Active Not RecruitingNCT05123131
What this trial is testing

Isa-RVD Study in Patients With Newly Diagnosed Multiple Myeloma

Who this might be right for
Multiple Myeloma
Cancer Trials Ireland 54
Testing effectiveness (Phase 2)Study completedNCT02046070
What this trial is testing

Phase 2 Study to Evaluate the Oral Combination of Ixazomib (MLN9708) With Cyclophosphamide and Dexamethasone in Patients With Newly Diagnosed or Relapsed and/or Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
Millennium Pharmaceuticals, Inc. 148
Large-scale testing (Phase 3)UnknownNCT03428373
What this trial is testing

Rivaroxaban or Aspirin As Thromboprophylaxis in Multiple Myeloma

Who this might be right for
Multiple Myeloma in RelapseMultiple Myeloma ProgressionMultiple Myeloma Stage II+3 more
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 57
Testing effectiveness (Phase 2)Study completedNCT01526694
What this trial is testing

Phase II Trial Designed to Determine Efficacy and Safety of Bendamustine+Dexamethasone+Thalidomide in R/R MM

Who this might be right for
Multiple Myeloma
Azienda Ospedaliera di Bolzano 30
Large-scale testing (Phase 3)Study completedNCT00058331
What this trial is testing

Epoetin Alfa in Treating Anemia in Patients With Solid Tumors

Who this might be right for
AnemiaLeukemiaLymphoma+4 more
Alliance for Clinical Trials in Oncology 365
Not applicableStudy completedNCT05061095
What this trial is testing

Understanding What Matters Most to Patients: Establishing the Validity of a Best-Worst Scaling Survey

Who this might be right for
Hematologic Neoplasms
UNC Lineberger Comprehensive Cancer Center 51
Testing effectiveness (Phase 2)Study completedNCT03412565
What this trial is testing

Evaluate Subcutaneous Daratumumab in Combination With Standard Multiple Myeloma Treatment Regimens

Who this might be right for
Multiple Myeloma
Janssen Research & Development, LLC 265
Testing effectiveness (Phase 2)Looking for participantsNCT04643002
What this trial is testing

Isatuximab in Combination With Novel Agents in RRMM - Master Protocol

Who this might be right for
Plasma Cell Myeloma Refractory
Sanofi 258
Testing effectiveness (Phase 2)Study completedNCT00448201
What this trial is testing

Reduced-Intensity Busulfan and Fludarabine With or Without Antithymocyte Globulin Followed by Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer or Other Disease

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+2 more
UNC Lineberger Comprehensive Cancer Center 71
Testing effectiveness (Phase 2)UnknownNCT03992170
What this trial is testing

Study of Daratumumab in Multiple Myeloma (MM) Patients in >VGPR/MRD-positive

Who this might be right for
Myeloma Multiple
Azienda Ospedaliera Universitaria Senese 50
Large-scale testing (Phase 3)Study completedNCT00049673
What this trial is testing

Thalidomide and Prednisone After Autologous Stem Cell Transplantation Multiple Myeloma

Who this might be right for
Multiple Myeloma and Plasma Cell Neoplasm
NCIC Clinical Trials Group 332
Not applicableLooking for participantsNCT06767254
What this trial is testing

A Machine Learning Approach to Connect Multiple Myeloma Complexity to Early Disease Recurrence

Who this might be right for
Multiple Myeloma (MM)
IRCCS Azienda Ospedaliero-Universitaria di Bologna 200
Testing effectiveness (Phase 2)Study completedNCT00007995
What this trial is testing

Chemotherapy Plus Peripheral Stem Cell Transplant in Treating Patients Who Have Multiple Myeloma or Primary Systemic Amyloidosis

Who this might be right for
Multiple Myeloma and Plasma Cell Neoplasm
Herbert Irving Comprehensive Cancer Center 75
Not applicableLooking for participantsNCT05879757
What this trial is testing

Real-world Usage of HyQvia in Multiple Myeloma Adults With Secondary Immunodeficiency

Who this might be right for
Multiple MyelomaSecondary Immunodeficiency (SID)
Takeda 75
Testing effectiveness (Phase 2)Ended earlyNCT03512353
What this trial is testing

Carfilzomib Plus Dexamethasone in Adults With Relapsed or Refractory Multiple Myeloma at US Community Oncology Centers

Who this might be right for
Relapsed or Refractory Multiple Myeloma
Amgen 7
Not applicableStudy completedNCT06483139
What this trial is testing

Novel Treatments in Improving Renal Outcomes in Light Chain Cast Nephropathy

Who this might be right for
Multiple MyelomaLight Chain NephropathyAcute Kidney Injury
Brigham and Women's Hospital 549
Testing effectiveness (Phase 2)Study completedNCT02078102
What this trial is testing

A Phase II Trial Using Meloxicam Plus Filgrastim in Patients With Multiple Myeloma and Non-Hodgkin's Lymphoma

Who this might be right for
Multiple MyelomaNon-Hodgkin's Lymphoma
Sherif S. Farag 38
Not applicableLooking for participantsNCT07292272
What this trial is testing

Halt Aging in Survivors of Blood Cancers

Who this might be right for
Hematological MalignancyLeukemiaLymphoid Leukemia+5 more
University of Nebraska 180
Next Page